The role of microbiological results in driving inappropriate antibiotic prescriptions
Loading...
Official URL
Full text at PDC
Publication date
2025
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott, Williams & Wilkins
Citation
Munoz P, Vena A, Burillo A, Bouza E. The role of microbiological results in driving inappropriate antibiotic prescriptions. Curr Opin Crit Care. 2025 Oct 1;31(5):505-512. doi: 10.1097/MCC.0000000000001314
Abstract
Este artículo revisa cómo la interpretación inadecuada de los resultados microbiológicos puede conducir a prescripciones antibióticas inapropiadas, incluso cuando las pruebas diagnósticas se solicitan o procesan correctamente. Se describen situaciones frecuentes como la sobreinterpretación de cultivos de orina, muestras respiratorias o heridas superficiales, la confusión entre colonización e infección y la solicitud de pruebas sin indicación clínica clara. Los autores analizan el concepto de diagnostic stewardship como una estrategia clave para mitigar este problema, actuando sobre las fases de solicitud, procesamiento e informe de los resultados microbiológicos. Se revisan intervenciones como la restricción de pruebas, la selección o rechazo de muestras de baja calidad, la modificación de informes, los comentarios interpretativos y las herramientas de apoyo a la decisión clínica (como el BLADDER score). El artículo concluye que los laboratorios de microbiología deben desempeñar un papel activo y colaborativo con los clínicos para mejorar la calidad diagnóstica, reducir el uso innecesario de antibióticos y reforzar los programas de optimización antimicrobiana.
Purpose of review: To highlight the unintended consequences of microbiological test results in driving inappropriate antimicrobial prescriptions, and to evaluate strategies - particularly from the perspective of diagnostic stewardship - that may mitigate this issue. Recent findings: Despite the critical role of microbiological data in guiding appropriate antimicrobial therapy, several studies have demonstrated that misinterpretation of such results frequently leads to unnecessary treatments. Common pitfalls include overinterpretation of positive cultures from poorly collected or clinically unwarranted samples, misclassification of colonization vs. infection, and excessive reliance on test results in the absence of supporting clinical evidence. Emerging diagnostic stewardship interventions - ranging from restricting sample processing and modifying test reporting to implementing decision support tools - have shown promising outcomes in reducing overtreatment without compromising patient safety. Specific examples include urine and wound cultures, respiratory specimens, and the diagnosis of Clostridioides difficile infection. Furthermore, educational and system-level strategies such as the BLADDER score or selective result reporting can improve decision-making at various stages of the diagnostic process. Summary: Microbiology laboratories play a pivotal role in antimicrobial stewardship and must actively support clinicians in avoiding diagnostic and therapeutic errors. While evidence supports multiple approaches to mitigate inappropriate prescriptions driven by microbiology results, their successful implementation requires interdisciplinary collaboration, tailored interventions, and ongoing evaluation of clinical impact. Diagnostic stewardship, when aligned with clinician education and robust reporting practices, is a crucial component in enhancing the accuracy of infection diagnosis and reducing antimicrobial overuse.
Purpose of review: To highlight the unintended consequences of microbiological test results in driving inappropriate antimicrobial prescriptions, and to evaluate strategies - particularly from the perspective of diagnostic stewardship - that may mitigate this issue. Recent findings: Despite the critical role of microbiological data in guiding appropriate antimicrobial therapy, several studies have demonstrated that misinterpretation of such results frequently leads to unnecessary treatments. Common pitfalls include overinterpretation of positive cultures from poorly collected or clinically unwarranted samples, misclassification of colonization vs. infection, and excessive reliance on test results in the absence of supporting clinical evidence. Emerging diagnostic stewardship interventions - ranging from restricting sample processing and modifying test reporting to implementing decision support tools - have shown promising outcomes in reducing overtreatment without compromising patient safety. Specific examples include urine and wound cultures, respiratory specimens, and the diagnosis of Clostridioides difficile infection. Furthermore, educational and system-level strategies such as the BLADDER score or selective result reporting can improve decision-making at various stages of the diagnostic process. Summary: Microbiology laboratories play a pivotal role in antimicrobial stewardship and must actively support clinicians in avoiding diagnostic and therapeutic errors. While evidence supports multiple approaches to mitigate inappropriate prescriptions driven by microbiology results, their successful implementation requires interdisciplinary collaboration, tailored interventions, and ongoing evaluation of clinical impact. Diagnostic stewardship, when aligned with clinician education and robust reporting practices, is a crucial component in enhancing the accuracy of infection diagnosis and reducing antimicrobial overuse.












